Don’t Miss: MediciNova Inc. (NASDAQ:MNOV), EnLink Midstream, LLC (NYSE:ENLC), Heron Therapeutics, Inc. (NASDAQ:HRTX), Avon Products Inc. (NYSE:AVP),

MediciNova Inc. (NASDAQ:MNOV) announced that an abstract regarding MediciNova’s ongoing clinical trial of MN-166 (ibudilast) in ALS (amyotrophic lateral sclerosis) has been accepted for dual presentation at the American Academy of Neurology (AAN) 68th Annual Meeting to be held April 15-21, 2016, at the Vancouver Convention Centre in Vancouver, BC, Canada.

MediciNova Inc. (NASDAQ:MNOV) belongs to Healthcare sector. Its weekly performance is -7.32%. On last trading day company shares ended up at $5.95. MediciNova Inc. (NASDAQ:MNOV) distance from 50-day simple moving average (SMA50) is 5.64%.

EnLink Midstream, LLC (NYSE:ENLC) announced that Barry E. Davis, President and Chief Executive Officer, and Michael J. Garberding, Executive Vice President and Chief Financial Officer, will attend and meet with investors at the Barclays MLP Corporate Access Day.

EnLink Midstream, LLC (NYSE:ENLC) shares advanced 12.75% in last trading session and ended the day at $10.08. ENLC Gross Margin is 27.00% and its return on assets is -3.40%. EnLink Midstream, LLC (NYSE:ENLC) quarterly performance is -38.79%.

Heron Therapeutics, Inc. (NASDAQ:HRTX) announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it anticipates concluding its review of the New Drug Application (NDA) of SUSTOL® (granisetron) Injection, extended release, by early April 2016. The Company is working closely with the FDA to facilitate the completion of its review.

On 03 March, Heron Therapeutics, Inc. (NASDAQ:HRTX) shares decreased -0.45% and was closed at $17.67. HRTX EPS growth in last 5 year was 4.10%. Heron Therapeutics, Inc. (NASDAQ:HRTX) year to date (YTD) performance is -33.82%.

Avon Products Inc. (NYSE:AVP) announced the close of their strategic partnership transaction (previously announced on December 17, 2015). This partnership includes the separation of Avon’s North America business into a privately-held company that is majority-owned and managed by an affiliate of Cerberus.

Avon Products Inc. (NYSE:AVP) ended the last trading day at $4.05. Company weekly volatility is calculated as 6.37% and price to cash ratio as 2.57. Avon Products Inc. (NYSE:AVP) showed a weekly performance of 8.29%.

Chevron Corporation (NYSE:CVX) announced on Friday, that it is placing its entire shallow acreage at the Gulf of Mexico (GoM) up for sale, in order to complete the asset divestiture plan by the end of 2017.

Chevron Corporation (NYSE:CVX) shares advanced 0.45% in last trading session and ended the day at $87.53. CVX Gross Margin is 40.60% and its return on assets is 1.70%. Chevron Corporation (NYSE:CVX) quarterly performance is -4.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *